Milestone Scientific Inc. (MLSS) |
| 0.292 0.005 (1.74%) 04-14 16:00 |
| Open: | 0.2923 |
| High: | 0.2949 |
| Low: | 0.2868 |
| Volume: | 357,658 |
| Market Cap: | 23(M) |
| PE Ratio: | -4.17 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.33 |
| Resistance 1: | 0.30 |
| Pivot price: | 0.28 |
| Support 1: | 0.25 |
| Support 2: | 0.21 |
| 52w High: | 1.11 |
| 52w Low: | 0.22 |
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Tue, 14 Apr 2026
Milestone Scientific Inc. (AMEX:MLSS) Q4 2025 earnings call transcript - MSN
Sun, 05 Apr 2026
Milestone Scientific Outlines High-Risk Turnaround in Earnings - TipRanks
Thu, 02 Apr 2026
Milestone Scientific Amends MOU With Innovest to Enable Planned Securities Offering - TradingView — Track All Markets
Thu, 02 Apr 2026
Milestone Scientific (NYSE: MLSS) amends Innovest MOU to aid offering - Stock Titan
Wed, 01 Apr 2026
Earnings call transcript: Milestone Scientific reports Q4 2025 loss, stock rises - Investing.com
Thu, 26 Mar 2026
Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call - The Globe and Mail
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |